William Blair on TransMedics Group (TMDX): 'We believe TransMedics’ second-quarter sales will exceed consensus estimates'
William Blair analyst Ryan Daniels reiterated an Outperform rating and {REMOVEPT} price target on TransMedics Group (NASDAQ: TMDX).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)